ArticleOncotarget2017

TLR signaling inhibitor, phenylmethimazole, in combination with tamoxifen inhibits human breast cancer cell viability and migration.

Anthony L Schwartz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.